Total Revenue By Major Geographic Area |
Net sales and profit by reportable segment for the three and nine months ended September 30, 2016 and 2015 are as follows: | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2016 | | 2015 | | 2016 | | 2015 | | (In thousands) | Segment Net Sales | | | | | | | | Specialty Surgical Solutions | $ | 159,409 |
| | $ | 147,085 |
| | $ | 468,767 |
| | $ | 433,834 |
| Orthopedics and Tissue Technologies | 90,923 |
| | 79,282 |
| | 267,644 |
| | 207,740 |
| Total revenues | $ | 250,332 |
| | $ | 226,367 |
| | $ | 736,411 |
| | $ | 641,574 |
| Segment Profit | | | | | | | | Specialty Surgical Solutions | $ | 67,148 |
| | $ | 61,017 |
| | $ | 188,126 |
| | $ | 183,674 |
| Orthopedics and Tissue Technologies | 27,727 |
| | 20,072 |
| | 74,027 |
| | 59,095 |
| Segment profit | 94,875 |
| | 81,089 |
| | 262,153 |
| | 242,769 |
| Amortization | (3,467 | ) | | (2,942) |
| | (10,410) |
| | (6,418) |
| Corporate and other | (61,313 | ) | | (68,153 | ) | | (177,173) |
| | (180,772 | ) | Operating income from continuing operations | $ | 30,095 |
| | $ | 9,994 |
| | $ | 74,570 |
| | $ | 55,579 |
|
The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following: | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2016 | | 2015 | | 2016 | | 2015 | | (In thousands) | United States | $ | 194,346 |
| | $ | 178,290 |
| | $ | 567,103 |
| | $ | 493,559 |
| Europe | 28,553 |
| | 24,275 |
| | 89,623 |
| | 75,046 |
| Rest of World | 27,433 |
| | 23,802 |
| | 79,685 |
| | 72,969 |
| Total Revenues | $ | 250,332 |
| | $ | 226,367 |
| | $ | 736,411 |
| | $ | 641,574 |
|
|